Login / Signup
The Model for End-stage Liver Disease 3.0 is not superior to the Model for End-stage Liver Disease-Na in predicting survival: A retrospective cohort study.
Fangfang Duan
Chen Liu
Hang Zhai
Min Quan
Jun Cheng
Song Yang
Published in:
Hepatology communications (2023)
The MELD 3.0 was not superior to the original MELD or the MELD-Na in predicting the mortality of patients with ARLD.
Keyphrases
</>
cardiovascular events
risk factors
type diabetes
coronary artery disease
free survival